About OCRA
About OCRA
OCRA is the world’s largest organization dedicated to fighting ovarian and all gynecologic cancers on all fronts while supporting patients and their families.
About OCRA
About OCRA
OCRA is the world’s largest organization dedicated to fighting ovarian and all gynecologic cancers on all fronts while supporting patients and their families.
Mission & Impact
Ovarian Cancer Research Alliance is the global leader in research funding and a trailblazer in the race to find a cure for ovarian and gynecologic cancers. Unafraid to challenge accepted wisdom, OCRA has taken powerful stances on everything from new recommendations for prevention to creating innovative, highly effective programs to promote education, advocacy, and awareness.
OCRA’s patient support programs, staffed by highly experienced social workers, are a model in the field. They offer dedicated assistance and empathetic support for those who need it most, no matter where they are in their cancer journey. Our goal is not only to improve treatments and attract the most gifted scientists to the field, but also to support patients and their families to ensure the best possible care and outcomes. We are passionately committed to inspiring hope, advancing science, and moving the world closer to a cure.
- Invested $140M in scientific breakthroughs
- $140M
- Helped secure $3.8B in federal research and education funding
- $3.8B
- Annually support more than 95K individuals through our programs
- 95K
Donate today
OCRA fulfills this mission by raising money — 81 cents of every dollar spent supports research and programs.
OCRA drives change and ignites hope
When it comes to curing ovarian cancer, only one organization has both a laser focus and a panoramic view.
Research
OCRA invests more funds into ovarian cancer research than any other public charity.
We are known for funding innovative projects, attracting young scientists and new energy to the field of ovarian cancer research. In addition, OCRA also supports mid-career scientists and senior researchers, investing in large grants for the latter to encourage collaboration among institutions.
Discover our research
Support and Knowledge
In times of adversity, OCRA offers hope and understanding.
OCRA’s compassionate Patient Support oncology social work team has decades of experience helping anyone touched by ovarian and any other gynecologic cancer. OCRA offers a comprehensive array of programs, including the following:
Find support
- Woman to Woman Peer Mentor Program – Available in more than 20 hospitals nationwide as well as virtually.
- Survivors Teaching Students® (STS) program – Ovarian cancer survivors and caregivers share their stories of diagnosis, treatment, and survivorship in medical education programs at more than 420 schools.
- Staying Connected Support Series – Led by our highly trained oncology social workers, our nationwide program of weekly and monthly online gatherings offer compassion, community, and support, including Express Yourself, sessions with therapeutic arts activities that ignite the joy of creativity, and Book Club, a monthly facilitated session that creates connection around a shared reading.
Advocacy
Advocacy is the lifeblood of change
OCRA has built a team of dedicated advocates who stand united in support of the cause. OCRA tirelessly urges Congress to prioritize the cause against ovarian cancer and related gynecologic cancers and is the only dedicated voice on Capitol Hill continuously advocating for hundreds of millions of dollars in federal research funding and for related health policies that benefit ovarian and all gynecologic cancer patients and survivors.
Take action now
Meet Our Team
OCRA’s effectiveness is due to the dedication and deep expertise of its outstanding staff, Board, and Scientific Advisory Committee members.
Our Partners & Sponsors
OCRA is fortunate to count many of the world’s leading companies and corporations as partners and sponsors. We thank them for supporting our mission to improve the lives of those affected by ovarian and other gynecologic cancers and to accelerate the search for a cure.
Conflict of Interest Statement — Industry Partners
- Corporate partners including industry do not shape OCRA’s agenda, research, or advocacy.
- In 2023, industry partners represented 8% of OCRA’s overall revenue.
- If an industry partner sponsors an OCRA program, grant, or educational materials, it is publicly acknowledged and the supporting company has no editorial or strategic input.
- Any reference to a specific commercial product or service does not constitute or imply an endorsement by OCRA of the product or service or its producer or provider. The views and opinions expressed in any referenced document or on any referenced website do not necessarily reflect those of OCRA.
News & Updates
Action Alert: Urge Congress to Pass Final Bill on Cancer Research Funding and Early Detection
The Congressional Appropriations Committees have released a combined FY2026 Defense/Labor, Health and Human Services bill—and it includes several critical investments and policy provisions that would significantly strengthen the federal response to ovarian and other gynecologic cancers. This bill represents meaningful progress for our community, but it is not final. Congress must act swiftly to advance and … Continued
OCRA Urges Immediate Passage of Bill Supporting Ovarian Cancer Research, Education, and Early Detection
The Ovarian Cancer Research Alliance today praised the release of the FY2026 Labor, Health and Human Services, Education, and Related Agencies appropriations bill by the Congressional Appropriations Committees and urged swift action to advance and enact the legislation. The bill includes critical funding and policy provisions supporting ovarian cancer research, education, and early detection. Add Your Voice … Continued
Ovarian Cancer Research Alliance Reports Year of Significant Progress Across Research, Advocacy, and Patient Support
Organization launches global initiatives, expands patient programs, strengthens policy leadership, and achieves record engagement in 2025 OCRA is grateful for our community’s generous support, which helped raise over $2.4 million, surpassing our year-end campaign goal and closing out a year of progress. NEW YORK, NY — [January 13, 2026] — In 2025, Ovarian Cancer Research Alliance (OCRA) delivered … Continued